Matches in Wikidata for { <http://www.wikidata.org/entity/Q73168740> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q73168740 description "artículu científicu espublizáu en payares de 1999" @default.
- Q73168740 description "im November 1999 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73168740 description "scientific article published on 01 November 1999" @default.
- Q73168740 description "wetenschappelijk artikel" @default.
- Q73168740 description "наукова стаття, опублікована в листопаді 1999" @default.
- Q73168740 name "Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention" @default.
- Q73168740 name "Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention" @default.
- Q73168740 type Item @default.
- Q73168740 label "Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention" @default.
- Q73168740 label "Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention" @default.
- Q73168740 prefLabel "Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention" @default.
- Q73168740 prefLabel "Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention" @default.
- Q73168740 P1433 Q73168740-1CF5EABD-04F3-4E86-8789-A9652E68DFFD @default.
- Q73168740 P1476 Q73168740-29B71D98-8869-4240-ACE8-E1AC28E162B5 @default.
- Q73168740 P2093 Q73168740-38DE02BA-1A6E-42FB-ADF8-316037625CB8 @default.
- Q73168740 P2093 Q73168740-6B066CD9-58E6-4BEA-8D5D-D741B19327CC @default.
- Q73168740 P2093 Q73168740-7106E14E-190D-4865-B0AD-9C700CDE6FCC @default.
- Q73168740 P2093 Q73168740-8E06417A-1A3B-443B-A1EF-CFD982AE3F5F @default.
- Q73168740 P2093 Q73168740-AA4CA45A-6656-4A39-8E01-6CB9CDB14862 @default.
- Q73168740 P304 Q73168740-C7D780FD-4E7B-467B-A8B9-96910AD77BEF @default.
- Q73168740 P31 Q73168740-ACB78590-1D7D-46B4-B2EB-5DB512534FC5 @default.
- Q73168740 P356 Q73168740-8D952B8A-1606-4C51-B24F-C792A847AAE8 @default.
- Q73168740 P407 Q73168740-51842D9F-7F5A-4FC3-9131-7930CB6F325C @default.
- Q73168740 P433 Q73168740-B4F67506-3C7F-4AE6-9779-798E0CD097EC @default.
- Q73168740 P478 Q73168740-B7F111F7-6D4D-4F85-A7BB-E5711BF0412F @default.
- Q73168740 P50 Q73168740-299C0C66-E6C7-4A17-911D-90B0B00D691E @default.
- Q73168740 P50 Q73168740-2AB0F547-D7A3-405D-8744-4AFE070E394A @default.
- Q73168740 P50 Q73168740-6A01FEAF-8272-4CD7-8AB0-C8982CF43258 @default.
- Q73168740 P577 Q73168740-A3701A93-D88E-46D1-82E1-BB4F0C16176E @default.
- Q73168740 P698 Q73168740-AA0AB487-2B5E-4019-8AFA-8A61AB0E0F4B @default.
- Q73168740 P356 01.CIR.100.19.1977 @default.
- Q73168740 P698 10556224 @default.
- Q73168740 P1433 Q578091 @default.
- Q73168740 P1476 "Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention" @default.
- Q73168740 P2093 "B S Coller" @default.
- Q73168740 P2093 "D J Moliterno" @default.
- Q73168740 P2093 "M L Rosenthal" @default.
- Q73168740 P2093 "N K Godfrey" @default.
- Q73168740 P2093 "S R Steinhubl" @default.
- Q73168740 P304 "1977-1982" @default.
- Q73168740 P31 Q13442814 @default.
- Q73168740 P356 "10.1161/01.CIR.100.19.1977" @default.
- Q73168740 P407 Q1860 @default.
- Q73168740 P433 "19" @default.
- Q73168740 P478 "100" @default.
- Q73168740 P50 Q46003804 @default.
- Q73168740 P50 Q5387640 @default.
- Q73168740 P50 Q63038136 @default.
- Q73168740 P577 "1999-11-01T00:00:00Z" @default.
- Q73168740 P698 "10556224" @default.